Cardiovascular inflammation has been the talk of the town in cardiology, and while Novo Nordisk was wise to pursue treating it, results from the ZEUS trial have led to a thunderous debate on whether or not it ever played a role in ASCVD. To test the inflammatory hypothesis directly, ZEUS enrolled more than 6,300 patients […] The post ZEUS Tells Us Inflammation Might Not Be the Answer appeared first on Cardiac Wire .